Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium

Digestion

Volumn 75, Issue 1, 2007, Pages 54-61

  Tahara, Tomomitsu ^a,b   Arisawa, Tomiyasu ^a   Shibata, Tomoyuki ^a   Wang, Fang Yu ^a   Nakamura, Masakatsu ^a   Sakata, Mikijyu ^a   Nagasaka, Mitsuo ^a   Takagi, Tamaki ^a   Kamiya, Yoshio ^a   Fujita, Hiroshi ^a   Nakamura, Masahiko ^a   Hasegawa, Shin ^a   Iwata, Masami ^a   Takahama, Kazuya ^a   Watanabe, Makoto ^a   Hirata, Ichiro ^a   Nakano, Hiroshi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

DNA methylation; Gastric cancer; Helicobacter pylori

Indexed keywords

PROTEIN P16; PROTEIN P21;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; CPG ISLAND; DENSITOMETRY; DISEASE ASSOCIATION; DNA EXTRACTION; DNA METHYLATION; ENDOSCOPY; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RADIOIMMUNOASSAY; RISK ASSESSMENT; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA METHYLATION; FEMALE; GASTRIC MUCOSA; GASTRITIS; GENES, P16; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 34248188782     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101775     Document Type: Article

References (32)

1. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994;4:536-540.
2. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP: Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998;23:5489-5494.
3. Sato F, Harpaz N, Shibata D, et al: Hyper-methylation of the p14 (ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res 2002;62:1148-1151.
4. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA: Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001;61:3573-3577.
5. Bian YS, Osterheld MC, Fontolliet C, Bosman FT, Benhattar J: p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. Gastroenterology 2002;122:1113-1121.
6. Wong DJ, Paulson TG, Prevo LJ, et al: p16 (INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res 2001;61:8284-8289.
7. Kaneto H, Sasaki S, Yamamoto H, et al: Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut 2001;48:372-377.
8. Chan AO, Lam SK, Wong BC, et al: Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003;52:502-506.
9. Maekita T, Nakazawa K, Mihara M, et al: High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006;12:989-995.
10. Chan AO, Peng JZ, Lam SK, et al : Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 2006;55:463-468.
11. Szaleczky E, Pronai L, Molnar B, Berczi L, Feher J, Tulassay Z: Increased cell proliferation in chronic Helicobacter pylori positive gastritis and gastric carcinoma - correlation between immuno-histochemistry and Tv image cytometry. Analyt Cell Pathol 2000;20:131-139.
12. Rizos H, Darmanian AP, Mann GJ, Kefford RF: Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization. Oncogene 2000;19:2978-2985.
13. Tannapfel A, Busse C, Weinans L, et al: INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene 2001;20:7104-7109.
14. Toyota M, Ahuja N, Suzuki H, et al: Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999;59:5438-5442.
15. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG: CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001;61:2847-2851.
16. Pestov DG, Strezoska Z, Lau LF: Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol 2001;21:4246-4255.
17. Polat A, Cinel L, Dusmez D, Aydin O, Egilmez R: Expression of cell-cycle related proteins in Helicobacter pylori gastritis and association with gastric carcinoma. Neoplasma 2002;49:95-100.
18. Kurosawa A, Miwa H, Hirose M, Tsune I, Nagahara A, Sato N: Inhibition of cell proliferation and induction of apoptosis by Helicobacter pylori through increased phosphorylated p53, p21 and Bax expression in endothelial cells. J Med Microbiol 2002;51:385-391.
19. Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-1276.
20. Parkin DM, Bray F, Ferlay J, Pisani P: 2 Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156.
21. Ekstrom AM, Held M, Hansson LE, Engstrand L, Nyren O: Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001;1214:784-791.
22. Forman D, Webb P, Parsonnet J: H. pylori and gastric cancer. Lancet 1994;343:243-244.
23. Uemura N, Okamoto S, Yamamoto S, et al: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
24. Asaka M, Kimura T, Kudo M, et al: Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760-766.
25. Kekki M, Samloff IM, Varis K, Ihamaki T: Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol 1991;186(suppl):109-116.
26. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
27. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston, 1994. Am J Surg Pathol 1996;20:1161-1181.
28. Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS: Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 2003;163:1551-1556.
29. Schembri MA, Lin SK, Lambert JR: Comparison of commercial diagnostic tests for Helicobacter pylori antibodies. J Clin Microbiol 1993;31:2621-2624.
30. Lee S, Hwang KS, Lee HJ, Kim JS, Kang GH: Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest 2004;84:884-893.
31. Ushijima T: Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 2005;5:223-231.
32. Correa P: Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19(suppl 1):S37-S43.